Benjamin L. Palleiko, CEO: KalVista Pharmaceuticals KALV Sell · Filed 25/05/20

Trade details

Type: Insider sale
Amount: $45,086.72
Shares · price: 3,808 sh · $11.84 a share
Held after: 293,367 sh
Stock: KalVista Pharmaceuticals KALV
Person: Benjamin L. PalleikoCEO
Trade date: 25/05/19
Filed: 25/05/20
Days to filing: 1 days

Sold 1.3% of holdings

Share of holding sold: 1.3%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/04/19~25/06/18

Benjamin L. Palleiko's recent trades

Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$292.6K
10,926 sh
$292.6K
Filed 05/26
Traded 05/22
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$30.2K
1,129 sh
$30.2K
Filed 05/19
Traded 05/18
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$88.7K
3,322 sh
$88.7K
Filed 05/13
Traded 05/12
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$193.1K
9,550 sh
$193.1K
Filed 04/20
Traded 04/17
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$107.6K
6,693 sh
$107.6K
Filed 03/10
Traded 03/09